+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report

  • ID: 1488451
  • Report
  • November 2019
  • Region: United States
  • 43 pages
  • IBISWorld
1 of 5
Chemical reaction: Generic operators willl likely explore new product lines to boost demand

FEATURED COMPANIES

  • Mylan Inc.
  • Sandoz Ltd.
  • MORE

Generic Pharmaceutical Manufacturing in the US

The Generic Pharmaceutical Manufacturing industry is expanding at a steady pace, with revenue expected to increase over the five years to 2019. Increasing access to health insurance, rising total health expenditure and efforts to control prescription medication costs benefited generic manufacturers. The increasing use of generic and biosimilar products has already resulted in trillions of dollars in savings for employers, health plans, patients and the government. Increasing price scrutiny of branded prescriptions has enabled generic manufacturers to take advantage of pricing pressures and improve patient access to medicine. Over the five years to 2024, generic manufacturers are expected to lobby for policies that encourage cost savings and access to affordable medicines. Furthermore, as a growing number of patents are set to expire over the coming years, generic manufacturers are expected to have robust product pipelines. During the outlook period, generic operators are expected to explore new product lines, including biosimilars, and expand into new and emerging markets where consumers can only afford generics.

Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Mylan Inc.
  • Sandoz Ltd.
  • MORE
ABOUT THIS INDUSTRY
  • Industry Definition
  • Main Activities
  • Similar Industries
  • Additional Resources
INDUSTRY AT A GLANCE

INDUSTRY PERFORMANCE
  • Executive Summary
  • Key External Drivers
  • Current Performance
  • Industry Outlook
  • Industry Life Cycle
PRODUCTS & MARKETS
  • Supply Chain
  • Products & Services
  • Demand Determinants
  • Major Markets
  • International Trade
  • Business Locations
COMPETITIVE LANDSCAPE
  • Market Share Concentration
  • Key Success Factors
  • Cost Structure Benchmarks
  • Basis of Competition
  • Barriers to Entry
  • Industry Globalization
MAJOR COMPANIES

OPERATING CONDITIONS
  • Capital Intensity
  • Technology & Systems
  • Revenue Volatility
  • Regulation & Policy
  • Industry Assistance
KEY STATISTICS
  • Industry Data
  • Annual Change
  • Key Ratios
JARGON & GLOSSARY
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Inc.
  • Sandoz Ltd.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll